Asthma and COPD
- Short-acting β2 agonists (SABA, e.g. salbutamol) relieve symptoms. Side effects: tremor, tachycardia, hypokalaemia.
- Long-acting β2 agonists (LABA: salmeterol, formoterol) must never be used alone in asthma. Always combine them with an inhaled corticosteroid (ICS).
- Inhaled corticosteroids (beclomethasone, budesonide, fluticasone) are the core controller therapy. They cause oral thrush and hoarseness, so patients should rinse their mouth after use.
- Tiotropium, a long-acting antimuscarinic (LAMA), is a mainstay in COPD. Ipratropium is short-acting.
- Theophylline has a narrow therapeutic range and toxicity causes seizures and arrhythmias. Ciprofloxacin and erythromycin raise its level; smoking lowers it.
- Montelukast blocks leukotriene receptors and is useful in aspirin-sensitive and exercise-induced asthma. Cromolyn is used only for prevention. Omalizumab targets IgE.
- Acute severe asthma: oxygen, nebulised salbutamol with ipratropium, systemic steroids, and IV magnesium sulfate.